Enabling base editing research via automation and a cloud connected lab
Base editing — a new class of precision genetic medicines — has the potential of providing life-long cures to patients suffering from serious diseases. However, base editing research is complex and demanding, requiring the processing of large sample amounts and tracking of complex data.
In this presentation, learn how Beam Therapeutics pioneers this novel therapeutic by leveraging automation and Benchling's unified, cloud-based R&D informatics platform.
Watch now
Hosted by
Bob Gantzer
Head of Lab Automation & Robotics at BEAM Therapeutics
Lauren Shields
Head of Solution and Value at Benchling